Southampton Joint Formulary Formulary

Introduction

Welcome to the Southampton Joint Medicines Formulary

Useful Links

Shared care guidelines DPC medicines guidance

Immunoglobulin forms (UHS)
Formulary applications (UHS)

Formulary applications (Southampton CCG)

Southampton City CCG University Hospital Southampton

NHS England Specialised Commissioning Documents NICE Guidance

NHS England Guidance for CCGs: Conditions for which over the counter items should not routinely be prescribed in primary care and implementation resources NHS England Guidance for CCGs: Items which should not be routinely prescribed in primary care

Medication Shortages info (UHS Only) MHRA Central Alerting System

Medicines Learning Portal Medicine Safety Portal

Covid-19 Resources

NHS England and NHS Improvement: COVID-19 Vaccination Programme Links to guidance for hospitals and primary care; equipment and consumables provision and supply, and vaccination information from other organisations	MHRA Guidance on COVID-19 Links to information and guidance on regulatory flexibilities, clinical trials, vaccines and vaccines safety, medicines and medical devices and COVID-19, and medical alerts related to COVID-19
NICE Covid-19 Hub Bringing together guidance, resources and other information that may help you.	Specialist Pharmacy Service Medicines Guidance Summaries Summarises and signposts to medicine related guidance from professional and government bodies
Public Health England COVID-19 Chapter: the green book Provides information on COVID-19 vaccines (dosage and schedule, recommendations for use etc)	Specialist Pharmacy Service: COVID-19 Vaccines Provides general information and answers to questions about all UK approved COVID-19 vaccines
MHRA Information on the AstraZeneca/Oxford COVID-19 Vaccine	MHRA Information on the Pfizer/BioNTech COVID-19 vaccine
MHRA Information on the Moderna COVID-19 Vaccine	British Medical Journal (BMJ) Covid-19 Hub includes links to guidance
UHS COVID-19 Vaccine Information for Staff (UHS staff only)	UHS COVID-19 Policies and Guidance (UHS staff only)

News Feed

Mar 2021: Joint guidance from the Specialist Pharmacy Service (SPS), Society for Endocrinology and the British Association of Dermatology "Exogenous steroids: adrenal insufficiency and adrenal crisis- who is at risk and how should they be managed safely" published to support implementation of the National Patient Safety Alert re: introduction of a new Steroid Emergency Card. Further information and guidance on adrenal crisis, including links to the new card are available on the Society for Endocrinology website endocrinology.org/adrenal-crisis

Dec 2020: Cumulative update list Southampton Medicines Formulary

Sept 2020: Home Office circular: cannabis-based medicine, Epidyolex, is to be placed in Schedule 5 to the Misuse of Drugs Regulations 2001.

April 2020: A joint letter from the UK’s four Chief Medical Officers and NHS England and Improvement’s’ National Medical Director to every NHS Trust in the country asks that all efforts are made to enrol patients into nationally prioritised clinical trials on COVID-19, and strongly discourages using off-licence treatments outside of a trial. Full letter here.

Drug Shortages or Discontinuations

The NHS in and around Southampton and West Hampshire reviews the use of medicines through the Basingstoke, Southampton and Winchester District Prescribing Committee (DPC). The main aim of the DPC is to ensure that there is a consistent approach to prescribing the most safe, efficacious and cost effective medicines across the local healthcare community. The Southampton Joint Medicines Formulary follows recommendations from the DPC, and is for use by all primary and secondary care prescribers within Southampton (See 'about’).

This formulary provides a list of medicines available for routine prescribing or those available within certain criteria. Unless otherwise stated, the medicines selected are recommended as first choice, particularly for new patients. Those patients stabilised on other therapies may be switched to a formulary drug if and when clinically appropriate.